Josh Beckerman

6 days ago | marketscreener.com | Josh Beckerman

VERASTEM, INC. Add to a list Real-time Estimate Cboe BZX 01:57:13 2025-05-08 pm EDT 5-day change 1st Jan Change 6.900 USD +3.14% -9.96% +29.40% Verastem Oncology Cancer Drug Combination Gets FDA Approval Published on 05/08/2025 at 13:55 Verastem Oncology said the Food and Drug Administration approved the combination of avutometinib capsules and defactinib tablets for certain patients with KRAS-mutated recurrent low-grade serous ovarian cancer.

6 days ago | tradingview.com | Josh Beckerman

Verastem Oncology Cancer Drug Combination Gets FDA ApprovalVSTMVerastem Oncology said the Food and Drug Administration approved the combination of avutometinib capsules and defactinib tablets for certain patients with KRAS-mutated recurrent low-grade serous ovarian cancer. The company expects a combination co-pack will be available in the U.S. in about a week. The approval was in advance of the June 30 Prescription Drug User Fee Act action date.

1 week ago | ca.marketscreener.com | Josh Beckerman

ASSET ENTITIES INC. Add to a list Market Closed - Nasdaq 16:00:00 2025-05-07 EDT 5-day change 1st Jan Change 3.390 USD +455.74% +484.48% +591.13% Asset Entities Surges Following Strive Asset Management Deal Published on 2025-05-07 at 13:37 Shares of Asset Entities jumped after the company said it will merge with Strive Asset Management, the investment firm co-founded by Vivek Ramaswamy. Asset Entities stock rose nearly fourfold, to $2.24, midday Wednesday.

1 week ago | tradingview.com | Josh Beckerman

Asset Entities Surges Following Strive Asset Management DealASSTShares of Asset Entities jumped after the company said it will merge with Strive Asset Management, the investment firm co-founded by Vivek Ramaswamy. Asset Entities stock rose nearly fourfold, to $2.24, midday Wednesday. Volume was more than 194 million shares, compared with a 65-day average of 3.6 million.

1 week ago | wsj.com | Josh Beckerman

The private-equity firm said Tuesday the deal is expected to include up to $242 million in cash and $418 million in equity payable at closing, subject to adjustmentsMay 6, 2025 7:27 pm ET|WSJ ProTPG agreed to buy Peppertree Capital Management, a digital infrastructure investment firm with a focus on wireless communications towers, with investor Affiliated Managers Group agreeing to sell its Peppertree stake as part of the deal.